StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
DARE

Daré Bioscience, Inc.

DARE Nasdaq Pharmaceutical Preparations EDGAR ↗
$1.32
+0.04 +3.13%

Key statistics

from XBRL data in SEC filings
Market cap
$19.8M
Revenue (TTM)
$1.03M
Net income (TTM)
-$12.0M
EPS (TTM)
$-0.91
P/E ratio
Dividend yield
Free cash flow
-$10.3M
Cash
$18.5M
Total assets
$27.8M
Gross margin
52-week range
$1.13 – $3.78

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Regulation FD disclosure Jul 24, 2026 8-K Delisting notice or listing-rule failure Jul 17, 2026 8-K Regulation FD disclosure Jul 13, 2026 8-K Regulation FD disclosure Jun 22, 2026 8-K Director or officer change; Shareholder vote results Jun 12, 2026 8-K Unregistered sale of equity May 18, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K Unregistered sale of equity May 7, 2026 8-K Regulation FD disclosure Apr 22, 2026 8-K Unregistered sale of equity Apr 20, 2026 8-K Director or officer change Apr 17, 2026 8-K Unregistered sale of equity Apr 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release) Mar 26, 2026 8-K Unregistered sale of equity Mar 17, 2026 8-K Unregistered sale of equity Mar 9, 2026 8-K Regulation FD disclosure Mar 2, 2026 8-K Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Other events Jan 29, 2026 8-K Regulation FD disclosure Jan 6, 2026 8-K Terminated a material agreement; Regulation FD disclosure Dec 1, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Regulation FD disclosure Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Other events Jul 25, 2025 8-K Other events Jul 21, 2025 8-K Regulation FD disclosure; Other events Jul 14, 2025 8-K Director or officer change; Shareholder vote results Jul 9, 2025 8-K Other events Jun 25, 2025 8-K Regulation FD disclosure Jun 9, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Other events Apr 11, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Delisting notice or listing-rule failure Feb 14, 2025 8-K Regulation FD disclosure Feb 10, 2025 8-K Regulation FD disclosure Jan 13, 2025